- Home
- LFCR
as 11-21-2024 4:00pm EST
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | CHASKA |
| Market Cap: | 164.3M | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 199.0K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.68 - $8.90 | Next Earning Date: | 10-04-2024 |
| Revenue: | $128,443,999 | Revenue Growth: | 23.42% |
| Revenue Growth (this year): | 2.23% | Revenue Growth (next year): | 8.40% |
Stock Insider Trading Activity of Lifecore Biomedical Inc. (LFCR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | LFCR | 10% Owner | Oct 3 '24 | Buy | $4.10 | 292,683 | $1,200,000.30 | 2,095,783 | |
| Kiper Christopher S | LFCR | Director10% Owner | Oct 3 '24 | Buy | $4.10 | 1,463,414 | $5,999,997.40 | 4,084,268 |
Latest Lifecore Biomedical Inc. News
LFCR Breaking Stock News: Dive into LFCR Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 hours ago
Lifecore Biomedical Hosts Virtual Investor Day
Insider Monkey
7 days ago
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
GlobeNewswire
9 days ago
Lifecore Biomedical to Present at Stephens Annual Investment Conference
Simply Wall St.
9 days ago
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds
GlobeNewswire
15 days ago
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
GlobeNewswire
18 days ago
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
MT Newswires
a month ago
Lifecore Biomedical Files Secondary Stock Shelf
GuruFocus.com
a month ago
Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc
Compare LFCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LFCR Lifecore Biomedical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.